Target intelligence / Profile preview

Conjugative resistance plasmids of Klebsiella pneumoniae

Molecular classification
Extrachromosomal DNA, Mobile genetic element
01

Overview

Conjugative plasmids in Klebsiella pneumoniae are autonomous, extrachromosomal DNA elements that serve as primary vehicles for the horizontal dissemination of antibiotic resistance genes. These plasmids are particularly notorious for carrying carbapenemase genes, such as blaKPC and blaNDM, which render infections nearly untreatable with standard-of-care beta-lactam antibiotics (Wyres & Holt, 2018). They utilize a Type IV secretion system to physically transfer genetic material between bacterial cells, often crossing species boundaries within the Enterobacteriaceae family (Navas-Tienda et al., 2024). In addition to resistance, these plasmids frequently harbor virulence factors and heavy metal resistance genes, providing a significant fitness advantage to the host bacterium in hospital settings. Therapeutic strategies targeting these plasmids, such as plasmid-curing agents or conjugation inhibitors, aim to disarm the bacteria rather than kill them directly, potentially reducing the selective pressure for new resistance mechanisms (Buckner et al., 2018). Emerging technologies like CRISPR-Cas9 are being explored to specifically eliminate these plasmids from bacterial populations, offering a precision medicine approach to managing multidrug-resistant Klebsiella infections.

Other names
R-plasmidsResistance plasmidspKPCpNDMMobile genetic elementsK. pneumoniae plasmidome
02

Mechanism of action

Inhibition of plasmid replication, interference with the Type IV secretion system (T4SS), or targeted degradation of plasmid DNA via CRISPR-Cas systems.

03

Biological functions

Horizontal gene transferBacterial conjugationAntibiotic resistance disseminationVirulence factor transport
04

Disease associations

InfectionSepsisPneumoniaUrinary tract infectionHealthcare-associated infection
05

Safety considerations

Off-target effects on beneficial gut microbiotaPotential for incomplete curing leading to rapid re-emergenceDelivery challenges for nucleic acid-based therapiesInduction of the SOS response in bacteria
06

Interacting drugs

Apramycin

3 more in the full profile.

07

Biomarkers

blaKPCblaNDMblaOXA-48IncFII repliconIncL/M replicon

Beyond the preview

Go deeper on Conjugative resistance plasmids of Klebsiella pneumoniae.

Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.

Drug pipeline

Full profile access

Explore the programs pursuing this target and their development progress.

  • Drug candidates
  • Developers
  • Development stage

Clinical trials

Full profile access

Follow the clinical studies evaluating therapies directed at this target.

  • Trial design
  • Status
  • Readouts

Competitive landscape

Full profile access

Compare approaches across drug candidates, modalities, and indications.

  • Programs
  • Modalities
  • Indications

Literature & evidence

Full profile access

Investigate the research and source evidence behind target biology and development.

  • Publications
  • Sources
  • Analysis

Patents

Full profile access

Explore patent activity around therapies and technologies addressing this target.

  • Patents
  • Assignees
  • Technologies

Research & analysis

Full profile access

Connect target biology, drug development, and emerging evidence in your research.

  • Biology
  • Development news
  • Analysis

Bring the full picture into focus.

See how Gosset can support your research on Conjugative resistance plasmids of Klebsiella pneumoniae.

Explore the full profile

Gosset Free

Get started with Gosset.

Enter your work email and we’ll be in touch with next steps.

Work email preferred.

Book a call